Morphine Sulfate Injection Recalled for Lack of Sterility Assurance
Nephron Sterile Compounding Center is recalling Morphine Sulfate Injection due to lack of assurance of sterility. The recall affects 5,495 pre-filled syringes distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is a Class II FDA recall for a sterile injectable drug with lack of assurance of sterility, which poses a potential contamination risk. No illnesses or injuries have been reported in the source material.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Morphine Sulfate Injection, USP, 50 mg/50 mL in pre-filled syringes. The recall involves 5,495 syringes packaged 5 per carton, with 6 cartons per case, distributed nationwide.
The affected lot numbers are MS2002A (expires 7/2/2022), MS2003A (7/30/2022), MS2005A (7/31/2022), MS2008A (8/23/2022), MS2013A (9/9/2022), MS2015A (9/26/2022), and MS2019A (10/14/2022).
The recall was initiated due to lack of assurance of sterility. This is classified as a Class II FDA recall.
The recalled product
- Product
- Morphine Sulfate Injection, USP, 50 mg/50 mL (1 mg/mL) syringe, packaged in 5 x 50 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-979-50
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable Opioid
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lots: MS2002A
- Exp. 7/2/2022
- MS2003A
- Exp. 7/30/2022
- MS2005A
- Exp. 7/31/2022
- MS2008A
- Exp. 8/23/2022
- MS2013A
- Exp. 9/9/2022
- MS2015A
- Exp. 9/26/2022
- MS2019A
- Exp. 10/14/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27